Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 922 of 1,261
  1. US 8183212

    Compound having GPR54 agonistic activity

    Takeda Pharmaceutical Company Limited · Granted May 22, 2012 · Expires May 17, 2032

    granted
  2. US 8183274

    Treatment of hyperproliferative disorders with diarylhydantoin compounds

    The Regents of the University of California · Granted May 22, 2012 · Expires May 17, 2032

    granted
  3. US 8183012

    Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

    The Regents of the University of California · Granted May 22, 2012 · Expires May 17, 2032

    granted
  4. US 8183009

    Assaying cellular markers for the evaluation of tumors

    Precision Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  5. US 8182860

    Dental filler

    JGC Catalysts and Chemicals Ltd. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  6. US 8182842

    Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted May 22, 2012 · Expires May 17, 2032

    granted
  7. US 8182835

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  8. US 8182801

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics · Granted May 22, 2012 · Expires May 17, 2032

    granted
  9. US 8183358

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 22, 2012 · Expires May 17, 2032

    granted
  10. US 8183014

    High affinity antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  11. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  12. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted
  13. US 8178679

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors

    Almirall, S.A. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  14. US 8178127

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  15. US 8178543

    Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  16. US 8178508

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 15, 2012 · Expires May 10, 2032

    granted
  17. US 8178555

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  18. US 8178671

    Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  19. US 8178534

    cMET inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  20. US 8178298

    Patched polypeptides and uses related thereto

    The Regents of the University of California · Granted May 15, 2012 · Expires May 10, 2032

    granted
  21. US 8178537

    Solid state forms of varenicline salts and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  22. US 8178109

    Compositions and methods of use for MGD-CSF in disease treatment

    Five Prime Therapeutics, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  23. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  24. US 8178076

    Diagnosis and assessment of skeletal related disease using calcium 41

    The Regents of the University of California · Granted May 15, 2012 · Expires May 10, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.